Treatment of cancer using a cd33 chimeric antigen receptor
US-2025353916-A1 · Nov 20, 2025 · US
This page is not indexed by search engines while we improve data quality.
Singh Reshma patents
Singh Reshma is listed as an inventor on 28 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Singh Reshma |
| Total patents | 28 |
| First publication | May 28, 2015 |
| Latest publication | Nov 20, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Mesothelin chimeric antigen receptor (car) and antibody against pd-l1 inhibitor for combined use in anticancer therapy
US-2025319179-A1 · Oct 16, 2025 · US
Treatment of cancer using a CD33 chimeric antigen receptor
US-12338287-B2 · Jun 24, 2025 · US
Treatment of cancer using humanized anti-BCMA chimeric antigen receptor
US-12214037-B2 · Feb 4, 2025 · US
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy
US-12186278-B2 · Jan 7, 2025 · US
Mesothelin chimeric antigen receptor (car) and antibody against pd-l1 inhibitor for combined use in anticancer therapy
US-2023000964-A1 · Jan 5, 2023 · US
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy
US-11413340-B2 · Aug 16, 2022 · US
Treatment of cancer using humanized anti-bcma chimeric antigen receptor
US-2022064316-A1 · Mar 3, 2022 · US
Anti-BCMA chimeric antigen receptor
US-11084880-B2 · Aug 10, 2021 · US
Treatment of cancer using a cd33 chimeric antigen receptor
US-2021139595-A1 · May 13, 2021 · US
Recent patents
Latest publications not already listed above.
Treatment of cancer using a CD33 chimeric antigen receptor
US-10851166-B2 · Dec 1, 2020 · US
Treatment of cancer using a cll-1 chimeric antigen receptor
US-2020215171-A1 · Jul 9, 2020 · US
Treatment of cancer using a CLL-1 chimeric antigen receptor
US-10568947-B2 · Feb 25, 2020 · US
System and apparatus for and methods of control of localized energy use in a building using price set points
US-10496066-B2 · Dec 3, 2019 · US
Treatment of cancer using 5 humanized anti-bcma chimeric antigen receptor
US-2019153061-A1 · May 23, 2019 · US
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
US-10174095-B2 · Jan 8, 2019 · US
Mesothelin chimeric antigen receptor (car) and antibody against pd-l1 inhibitor for combined use in anticancer therapy
US-2019000944-A1 · Jan 3, 2019 · US
Listeria-based adjuvants
US-10064898-B2 · Sep 4, 2018 · US
Combination Therapies With Recombinant Listeria Strains
US-2018153974-A1 · Jun 7, 2018 · US
System and apparatus for and methods of control of energy use in a building
US-2018059633-A1 · Mar 1, 2018 · US
Treatment of cancer using a cd33 chimeric antigen receptor
US-2018044423-A1 · Feb 15, 2018 · US
Treatment of cancer using a CD33 chimeric antigen receptor
US-9777061-B2 · Oct 3, 2017 · US
Listeria-based adjuvants
US-2016324903-A1 · Nov 10, 2016 · US
Listeria-based adjuvants
US-9463227-B2 · Oct 11, 2016 · US
Treatment of cancer using a cd33 chimeric antigen receptor
US-2016096892-A1 · Apr 7, 2016 · US
Treatment of cancer using a cll-1 chimeric antigen receptor
US-2016051651-A1 · Feb 25, 2016 · US
Treatment of cancer using humanized anti-bcma chimeric antigen receptor
US-2016046724-A1 · Feb 18, 2016 · US
System and Method for Solar Powered Thermal Management and Transport
US-2015143823-A1 · May 28, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Pennsylvania | 25 |
| Novartis Ag | 21 |
| Singh Reshma | 5 |
| Dana Farber Cancer Inst Inc | 5 |
| Harvard College | 5 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 23 |
| C07K2317/622 | 21 |
| A61K40/11 | 21 |
| C07K14/705 | 17 |
| A61K45/06 | 17 |